Cargando…
Rituximab for plasma exchange-dependent recurrent focal segmental glomerulosclerosis after renal transplantation
Autores principales: | Deegens, Jeroen K. J., Wetzels, Jack F. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477908/ https://www.ncbi.nlm.nih.gov/pubmed/28657033 http://dx.doi.org/10.1093/ndtplus/sfm048 |
Ejemplares similares
-
A retrospective study of focal segmental glomerulosclerosis: clinical criteria can identify patients at high risk for recurrent disease after first renal transplantation
por: Maas, Rutger JH, et al.
Publicado: (2013) -
Novel mouse strains to study circulating permeability factor(s) in primary focal segmental glomerulosclerosis
por: den Braanker, Dirk, et al.
Publicado: (2022) -
Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients
por: Park, Hoon Suk, et al.
Publicado: (2014) -
Plasma Exchange for the Recurrence of Primary Focal Segmental Glomerulosclerosis in Adult Renal Transplant Recipients: A Meta-Analysis
por: Vlachopanos, Georgios, et al.
Publicado: (2015) -
Pediatric focal segmental glomerulosclerosis: favorable transplantation outcome with plasma exchange
por: Fadel, Fatina I., et al.
Publicado: (2021)